Effect of systemic adjuvant treatment on first sites of breast cancer relapse
暂无分享,去创建一个
G Marini | M. Tattersall | J. Forbes | R. Gelber | A. Goldhirsch | M. Castiglione | A. Coates | H. Senn | K. Price | C. Rudenstam | J. Lindtner | J. Collins | J. Forbes | A Goldhirsch | H. Cortés-Funes | K. Brunner | G. Marini | H Cortés-Funes | C-M Rudenstam | M Castiglione | H-J Senn | J Collins | R. D Gelber | K. N Price | A. S Coates | J Lindtner | A Hacking | M Byrne | G Schnürch | K. W Brunner | M.H.N Tattersall | J Forbes | M. Tattersall | M. Byrne | A. Hacking | G. Schnürch
[1] Mike Clarke,et al. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992 .
[2] F. Cavalli,et al. Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast Cancer , 1991 .
[3] B Fisher,et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.
[4] F. Cavalli,et al. METHOTREXATE/NITROUS-OXIDE TOXIC INTERACTION IN PERIOPERATIVE CHEMOTHERAPY FOR EARLY BREAST CANCER , 1987, The Lancet.
[5] J. Silber,et al. CHEMOENDOCRINE VERSUS ENDOCRINE THERAPY IN BREAST CANCER , 1984, The Lancet.
[6] R Peto,et al. Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.
[7] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[8] I. Henderson,et al. Cancer of the breast: the past decade (first of two parts). , 1980, The New England journal of medicine.
[9] G. Friedell,et al. Identification of breast cancer patients with high risk of early recurrence after radical mastectomy. II. Clinical and pathological correlations , 1978, Cancer.
[10] Donegan Wl. Patterns and prognosis of advanced breast carcinoma. , 1970 .
[11] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[12] R. Gelber,et al. A single perioperative adjuvant chemotherapy course for node-negative breast cancer: five-year results of trial V. International Breast Cancer Study Group (formerly Ludwig Group). , 1992, Journal of the National Cancer Institute. Monographs.
[13] A. D. Schryver,et al. Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women: 1 , 1992 .
[14] M. Zelen,et al. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. , 1989, The New England journal of medicine.
[15] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[16] R. Gelber,et al. Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. Gelber,et al. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies. , 1986, NCI monographs : a publication of the National Cancer Institute.
[18] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .